Company Name : AiRat (Miyagi)<\/p>\n\n\n\n
Web Page : https:\/\/en.legalontech.jp\/<\/a><\/p>\n\n\n\n Stage : Series A<\/p>\n\n\n\n Total Raise Amount : \u00a5579 Million<\/p>\n\n\n\n <\/p>\n\n\n\n AiRato Inc., a Miyagi-based startup developing proprietary AI-powered radiation therapy planning software, announces the completion of a \u00a5460 million (approx. USD\u202f3.3 million) first close of its Pre-Series A funding round.<\/strong><\/p>\n\n\n\n This round includes follow-on investments from existing backers Chiiki to Hito to Mirai Co., Ltd. , GxPartners LLP, and Mint, along with new participation from Nissay Capital Co., Ltd., Sumitomo Corporation, and 77 Capital Co., Ltd. With this first close, AiRato\u2019s total funding to date has reached \u00a5580 million (approx. USD\u202f4.2 million).<\/p>\n\n\n\n AiRato aims to revolutionize cancer treatment by maximizing the potential of radiation therapy through AI. The company envisions a future where advanced, minimally invasive, and completely pain-free radiation treatments are widely accessible, saving the lives of cancer patients worldwide.<\/p>\n\n\n\n Radiation therapy, one of the three pillars of cancer treatment, has become increasingly vital in aging societies due to its low physical burden on patients. Among cutting-edge techniques, Intensity-Modulated Radiation Therapy (IMRT) has gained significant traction in recent years for its effectiveness.<\/p>\n\n\n\n However, IMRT faces two major challenges:<\/p>\n\n\n\n These challenges have limited the widespread adoption of IMRT, leaving many patients without access to its benefits.<\/p>\n\n\n\n To address this, AiRato is developing and commercializing AI-driven radiation therapy planning software. The software leverages AI to automate critical processes such as tumor and organ contouring, determination of irradiation areas, and safety verification\u2014cutting the time required for treatment planning from six hours to just 10\u201320 minutes.<\/p>\n\n\n\n This innovation enables the delivery of high-quality, safe radiation therapy plans, unlocking IMRT\u2019s full potential and positioning AiRato as a global leader in radiation oncology technology.<\/p>\n\n\n\n <\/p>\n\n\n\n <\/p>\n\n\n\n [source]<\/p>\n\n\n\n https:\/\/en.legalontech.jp\/<\/a><\/p>\n\n\n\n <\/p>\n","protected":false},"excerpt":{"rendered":" Company Name : AiRat (Miyagi) Web Page : https:\/\/en.legalontech.jp\/ Stage : Series A Total Raise Amount : \u00a5579 Million AiRato Inc., a Miyagi-based startup developing proprietary AI-powered radiation therapy planning software, announces the completion of a \u00a5460 million (approx. USD\u202f3.3 million) first close of its Pre-Series A funding round. This round includes follow-on investments from … Read More “AiRato Inc., Developer of AI-Based Cancer Radiation Therapy Devices, Secures \u00a5460 Million in First Close of Pre-Series A Funding”<\/span> »<\/a><\/p>\n","protected":false},"author":1,"featured_media":30,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[8],"class_list":["post-26","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-device","tag-early-stage"],"_links":{"self":[{"href":"https:\/\/www.startupjapantoday.com\/index.php?rest_route=\/wp\/v2\/posts\/26","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.startupjapantoday.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.startupjapantoday.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.startupjapantoday.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.startupjapantoday.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=26"}],"version-history":[{"count":6,"href":"https:\/\/www.startupjapantoday.com\/index.php?rest_route=\/wp\/v2\/posts\/26\/revisions"}],"predecessor-version":[{"id":93,"href":"https:\/\/www.startupjapantoday.com\/index.php?rest_route=\/wp\/v2\/posts\/26\/revisions\/93"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.startupjapantoday.com\/index.php?rest_route=\/wp\/v2\/media\/30"}],"wp:attachment":[{"href":"https:\/\/www.startupjapantoday.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=26"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.startupjapantoday.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=26"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.startupjapantoday.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=26"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n\n\n\nAiRato\u2019s Vision for the Future<\/strong><\/h3>\n\n\n\n
\n\n\n\nChallenges in Radiation Therapy and AiRato\u2019s Approach<\/strong><\/h3>\n\n\n\n
\n